METTL14 and neoplasm: Consistent with the aggressive tumor progression, mice grafted with PBT707 cells with KD of METTL3 or METTL14 alone or KD of both METTL3 and METTL14 had considerably worse survival outcomes than mice grafted with control GSCs (Figure 5E).